Inhibition of intestinal tumor formation by deletion of the DNA methyltransferase 3a

Oncogene

Volumn 34, Issue 14, 2014, Pages 1822-1830

  Weis, B ^a   Schmidt, J ^a   Maamar, H ^b   Raj, A ^b   Lin, H ^c   Toth C ^d,e   Riedmann, K ^a   Raddatz, G ^a   Seitz, H K ^d   Ho, A D ^f   Lyko, F ^a   Linhart, H G ^a,d,f  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CDKN1C PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1C; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A; HOMEODOMAIN PROTEIN; MUCIN; MUSCLE PROTEIN; NANOG PROTEIN, MOUSE; OCTAMER TRANSCRIPTION FACTOR 4; PEPTIDE; POU5F1 PROTEIN, MOUSE; TFF2 PROTEIN, MOUSE;

ADENOMA; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CANCER STEM CELL; CELL TRANSFORMATION; COLON; COLORECTAL TUMOR; DNA METHYLATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; PATHOLOGY; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ADENOMA; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUCINS; MUSCLE PROTEINS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PEPTIDES; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84900367930     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.114     Document Type: Article

References (38)

1. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
2. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99: 247-257.
3. Hsieh C-L. In vivo activity of murine de novo methyltransferases, Dnmt3a and Dnmt3b. Mol Cell Biol., 1999; 19: 8211-8218.
4. Samuel MS, Suzuki H, Buchert M, Putoczki TL, Tebbutt NC, Lundgren-May T et al. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling. Gastroenterology 2009; 137: 902-913.
5. Linhart HG, Lin H, Yamada Y, Moran E, Steine EJ, Gokhale S et al. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 2007; 21: 3110-3122.
6. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE et al. DNMT3A mutations in acute myeloid leukemia. New Engl J Med 2010; 363: 2424-2433.
7. Gao Q, Steine EJ, Barrasa MI, Hockemeyer D, Pawlak M, Fu D et al. Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression. Proc Natl Acad Sci USA 2011; 108: 18061-18066.
8. Nguyen S, Meletis K, Fu D, Jhaveri S, Jaenisch R. Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan. Dev Dyn 2007; 236: 1663-1676.
9. Saam JR, Gordon JI. Inducible gene knockouts in the small intestinal and colonic epithelium. J Biol Chem 1999; 274: 38071-38082.
10. Lin H, Yamada Y, Nguyen S, Linhart H, Jackson-Grusby L, Meissner A et al. Suppression of Intestinal Neoplasia by Deletion of Dnmt3b. Mol Cell Biol 2006; 26: 2976-2983.
11. Weis B, Schmidt J, Lyko F, Linhart H. Analysis of conditional gene deletion using probe based Real-Time PCR. BMC Biotechnol 2010; 10: 75.
12. Yamada Y, Mori H. Multistep carcinogenesis of the colon in ApcMin/+ mouse. Cancer Sci 2007; 98: 6-10.
13. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32: e38.
14. Li JY, Pu MT, Hirasawa R, Li BZ, Huang YN, Zeng R et al. Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. Mol Cell Biol 2007; 27: 8748-8759.
15. Kaneda M, Okano M, Hata K, Sado T, Tsujimoto N, Li E et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 2004; 429: 900-903.
16. Peterson AJ, Menheniott TR, O'Connor L, Walduck AK, Fox JG, Kawakami K et al. Helicobacter pylori infection promotes methylation and silencing of Trefoil Factor 2, leading to gastric tumor development in mice and humans. Gastroenterology 2010; 139: 2005-2017.
17. Katoh M. Trefoil factors and human gastric cancer (review). Int J Mol Med 2003; 12: 3-9.
18. Kavanagh E, Joseph B. The hallmarks of CDKN1C (p57, KIP2) in cancer. Biochimica et Biophysica Acta 2011; 1816: 50-56.
19. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995; 9: 650-662.
20. Figliola R, Busanello A, Vaccarello G, Maione R. Regulation of p57KIP2 during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation. J Mol Biol 2008; 380: 265-277.
21. Jeong M, Sun D, Luo M, Huang Y, Challen GA, Rodriguez B et al. Large conserved domains of low DNA methylation maintained by Dnmt3a. Nat Genet 2014; 46: 17-23.
22. Hon GC, Rajagopal N, Shen Y, McCleary DF, Yue F, Dang MD et al. Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat Genet 2013; 45: 1198-1206.
23. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128: 683-692.
24. Tang YA, Lin RK, Tsai YT, Hsu HS, Yang YC, Chen CY et al. MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer. Clin Cancer Res 2012; 18: 4325-4333.
25. He S, Wang F, Yang L, Guo C, Wan R, Ke A et al. Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer. PLoS ONE 2011; 6: e27684.
26. Bai X, Song Z, Fu Y, Yu Z, Zhao L, Zhao H et al. Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer. PLoS ONE 2012; 7: e40024.
27. Luczak MW, Roszak A, Pawlik P, Kedzia H, Kedzia W, Malkowska-Walczak B et al. Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma. Int J Oncol 2012; 40: 860-866.
28. Rahman MM, Qian ZR, Wang EL, Yoshimoto K, Nakasono M, Sultana R et al. DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors. Hum Pathol 2010; 41: 1069-1078.
29. Qu Y, Mu G, Wu Y, Dai X, Zhou F, Xu X et al. Overexpression of DNA methyltransferases 1, 3a, and 3b significantly correlates with retinoblastoma tumorigenesis. Am J Clin Pathol 2010; 134: 826-834.
30. Hlady RA, Novakova S, Opavska J, Klinkebiel D, Peters SL, Bies J et al. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis. J Clin Invest 2012; 122: 163-177.
31. Raddatz G, Gao Q, Bender S, Jaenisch R, Lyko F. Dnmt3a protects active chromosome domains against cancer-associated hypomethylation. PLoS Genet 2012; 8: e1003146.
32. Fujimoto K, Beauchamp RD, Whitehead RH. Identification and isolation of candidate human colonic clonogenic cells based on cell surface integrin expression. Gastroenterology 2002; 123: 1941-1948.
33. Yamada Y, Jackson-Grusby L, Linhart H, Meissner A, Eden A, Lin H et al. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci USA 2005; 102: 13580-13585.
34. Steine EJ, Ehrich M, Bell GW, Raj A, Reddy S, van Oudenaarden A et al. Genes methylated by DNA methyltransferase 3b are similar in mouse intestine and human colon cancer. J Clin Invest 2011; 121: 1748-1752.
35. Raj A, van den Bogaard P, Rifkin SA, van Oudenaarden A, Tyagi S. Imaging individual mRNA molecules using multiple singly labeled probes. Nat Methods 2008; 5: 877-879.
36. Kinney SM, Chin HG, Vaisvila R, Bitinaite J, Zheng Y, Esteve PO et al. Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes. J Biol Chem 2011; 286: 24685-24693.
37. Morey Kinney SR, Smiraglia DJ, James SR, Moser MT, Foster BA, Karpf AR. Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Res 2008; 6: 1365-1374.
38. Karimi M, Johansson S, Stach D, Corcoran M, Grandér D, Schalling M et al. LUMA (LUminometric Methylation Assay)-A high throughput method to the analysis of genomic DNA methylation. Exp Cell Res 2006; 312: 1989-1995.